ArticleFrontiers in immunology2022

SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients.

Jitka Smetanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.